Skip to main content

Advertisement

Table 3 Estimated inverse probability of treatment weight (IPTW) and stabilized inverse probability of treatment weight (SIPTW) of starting 1st ASCT (A), of starting consolidation therapy (B) and total product (TSIPTW) (C), respectively

From: Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma

  Mean ± Standard Deviation Range
Starting 1st ASCT (A)
 IPTW 2.00 ± 2.75 1.03–20.88
 SIPTW 1.00 ± 0.21 0.29–2.62
Starting Consolidation Therapy (B)
 IPTW 1.87 ± 2.52 1.00–31.75
 SIPTW 1.00 ± 0.37 0.43–5.79
Total Product (C)
 IPTW 2.99 ± 3.74 1.09–34.67
 SIPTW 1.00 ± 0.42 0.29–5.53